Author： Hughes D.A. Bagust A. Haycox A. Walley T.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.19, Iss.12, 2001-01, pp. : 1185-1197
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmacoeconomic Impact of Non-Compliance with Statins
By Andrew M. Peterson William F. McGhan
PharmacoEconomics, Vol. 23, Iss. 1, 2005-01 ,pp. :
Access to resources
Recommend
The Need for Pharmacoeconomic Evaluations in the NHS
By Griffin J.P.
PharmacoEconomics, Vol. 14, Iss. 3, 1998-09 ,pp. :
Budget impacts and pharmacoeconomic evaluations
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. :
Reporting Pharmacoeconomic Evaluations
By Carswell C.I. Paladino J.A.
PharmacoEconomics, Vol. 23, Iss. 11, 2005-01 ,pp. :
The Role of Pharmacoeconomic Evaluations in Disease Management
PharmacoEconomics, Vol. 14, Iss. 1, 1998-07 ,pp. :